PHAXIAM THERAPEUTICS Announces the Launch of a Process to Find Buyers in the Context of its ...
PHAXIAM Therapeutics (Euronext: PHXM - FR001400K4B1), a biopharmaceutical company ("PHAXIAM" or "the Company") developing innovative treatments for severe and resistant bacterial infections, announces ...